about
A pyrrolyl-based triazolophane: a macrocyclic receptor with CH and NH donor groups that exhibits a preference for pyrophosphate anionsPhotoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugateBismuth- and lead-texaphyrin complexes: towards potential α-core emitters for radiotherapy.A self-assembling lanthanide molecular nanoparticle for optical imagingLanthanide nano-drums: a new class of molecular nanoparticles for potential biomedical applications.Targeting Antioxidant Pathways with Ferrocenylated N-Heterocyclic Carbene Supported Gold(I) Complexes in A549 Lung Cancer Cells.A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding.Texaphyrins: tumor localizing redox active expanded porphyrinsDiscovery of Quinoline-Derived Trifluoromethyl Alcohols, Determination of Their in vivo Toxicity and Anticancer Activity in a Zebrafish Embryo Model.Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells.Molecular recognition of a thymine bulge by a high affinity, deazaguanine-based hydrogen-bonding ligand.Dual targeting of the cancer antioxidant network with 1,4-naphthoquinone fused Gold(i) N-heterocyclic carbene complexes.Hypoxia-targeted drug deliveryTargeting Heterogeneous Tumors Using a Multifunctional Molecular ProdrugExpanding the biological utility of bis-NHC gold(i) complexes through post synthetic carbamate conjugationToward multifunctional anticancer therapeutics: post-synthetic carbonate functionalisation of asymmetric Au(i) bis-N-heterocyclic carbenes
P50
Q34234911-B34E4963-F74E-4DF8-B181-3EE20139935CQ34562569-C9EC776C-6233-440A-9E3A-E96DD5AEE4BFQ35401128-769657B2-4E21-4019-8F8A-852E04CA0916Q35462282-B1D12CDF-2771-4B07-B0F4-F18D15CD3435Q35529352-A0565474-CF9D-4BF0-99E5-5DC7CC403C09Q36604338-9574B163-14E3-4CED-A406-5F60CB1E8E03Q37364023-5964619E-C8EA-4B20-8593-8F1675C51A09Q37847606-3107099E-83AE-4D75-8476-352AC0430155Q38833965-F34C08E3-F8FD-40E6-A008-C62FE0795EAEQ42096308-7FC9A40D-D547-4741-9453-9B68E150A169Q42544263-4576B073-200F-4DC3-9E42-C6A0EA8AB0C9Q46074494-02C06C5B-8B18-4E74-B4C8-99114556D464Q52331600-A864B2A2-5F63-4502-A060-F0EFD5244722Q61799902-0CED1932-FD8D-478B-8174-243D5C735936Q90059187-93DE8B3A-AA70-4D39-9A25-2658F78AA916Q92721301-179B4B6F-6D00-4712-B119-4DEE3EDCD2CFQ96289336-D09964FF-5A94-4733-99CE-5FBEB250F79A
P50
description
investigador
@es
researcher
@en
name
Jonathan F Arambula
@en
type
label
Jonathan F Arambula
@en
prefLabel
Jonathan F Arambula
@en
P31
P496
0000-0003-2342-8440